Home Top Movers Here’s why Soligenix, Inc. (SNGX) stock is Popping High today

Here’s why Soligenix, Inc. (SNGX) stock is Popping High today

Soligenix, Inc. (SNGX) stock gained Pediatric Investigation Plan (PIP) waiver for HyBryte™ (SGX301 or hypericin) by European Medicines Agency (EMA) after which the SNGX stock price saw an uptrend of 10.26% to reach $1.29 a share at the time of this writing. The stock went high in the previous trading session following the receival of $865,000in non-dilutive funding news and closed with a 4.46% gain. Let’s discuss more about SNGX stock.

Get the hottest stocks to trade every day before the market opens 100% ‎free. Click here now. 

What’s Happening?

The Pediatric Investigation Plan waiver is for HyBryte™ which had been evaluated against early-stage cutaneous T-cell lymphoma(CTCL) in phase three clinical study. The phase three study has been successfully concluded recently. This Achievement will pace up the marketing approval process of Soligenix’s application across the globe. Soligenix management is looking forward to marketing approval as well as commercialization of HyBryte™ and the first target market would be the U.S market which would then followed by the European market.


3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Sponsored


Read More

Non-Dilutive Funding:

Soligenix stock Yesterday on June 9, 2021, announced the receival of $865,000 amount, in non-dilutive funding under the state of New Jersey’s Technology Business Tax Certificate Transfer Program. It’s the eleventh year that SNGX stock is receiving funding for net operating loss. Roughly $6.5 million non-dilutive funding has been received by SNGX stock in this period that has enabled the Soligenix stock to advance its rare disease pipeline.

Recent Developments by SNGX stock:

  • On May 20, 2021, SNGX stock received the Japanese patent titled “Systems and Methods for Producing Synthetic Hypericin” in order to produce the highly purified form of synthetic hypericin
  • About a month ago, the United Kingdom’s(UK’s) Innovative Licensing and Access Pathway (ILAP) had awarded an innovation passport to SNGX stock’s HyBryte™ for the treatment of early-stage cutaneous T-cell lymphoma in adults.
  • In the Annual Conference on Vaccinology Research, the senior vice president, and Chief Scientific Officer, Oreola Donini, Ph.D. of Soligenix stock presented the CiVax™development program in mice and non-human primates (NHPs). CiVax™ is the vaccine against COVID-19.
  • On April 7, the HyBryte™ had been conditionally accepted as SGX301 by the U.S Food and Drug Administration.

Financial View of  SNGX stock:

SNGX stock revenue reduced to $0.1 million for the first three months of 2021 from $0.9 million in the same period of the previous year. Its net loss for the recently reported quarter was $2.4 million, or ($0.06) per share. $1.4 million amount spent on research and development expenses and $0.9 million used in general and administrative expenses by the SNGX stock.SNGX stock’s cash position was  $30.5 million by the end of March 2021.

Get the hottest stocks to trade every day before the market opens 100% ‎free. Click here now. 

Conclusion:

So far so good for SNGX stock as far as market sentiment is concerned. Soligenix is deeply focused on the treatment of CTCL via its HyBryte™. The stock is moving forward day by day and can be a good bet for investors in the long run.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Must Read

Oragenics Inc. (OGEN) stock gained during current market. What’s driving it high?

Oragenics Inc. (OGEN) stock gains by 54.33% during the current market trading session. Oragenics, is a research and development firm focused on combating infectious...

Flora Growth Corp. (FLGC) stock declines during premarket. Here’s what you should know?

Flora Growth Corp. (NASDAQ: FLGC) stock gained by 49.67% at last close whereas the FLGC stock price plunged by 18.36% in the pre-market trading...

Palatin Technologies Inc. (PTN) stock rises during pre-market trading. What has been happening lately?

Palatin Technologies Inc. (NASDAQ: PTN) stock declined by 1.16% the last close whereas the PTN stock price gains by 3.91% in the pre-market trading...

Smith Micro Develops Inc. (SMSI) stock soars during current market trading. Here’s to know why?

Smith Micro Develops Inc. (NASDAQ: SMSI) stock surged by 2.39% during the current market trading session. Smith Micro creates software that simplifies and improves...

Drive Shack Inc. (DS) stock soars during after-hour trading, followed by no recent update

Drive Shack Inc. (NASDAQ: DS) stock declined by 3.94% at last close while the DS stock-price surged by 7.38% in the after-hour session. Drive...

Oragenics Inc. (OGEN) stock gained during current market. What’s driving it high?

Oragenics Inc. (OGEN) stock gains by 54.33% during the current market trading session. Oragenics, is a research and development firm focused on combating infectious...

Tonix Pharmaceutics Holdings Inc. (TNXP) stock gains during current market. What’s driving it high?

Tonix Pharmaceuticals Holdings Inc. (TNXP) stock gains by 2.81% in the current market trading session. Tonix is a clinical-stage biopharmaceutical business dedicated on finding,...

Intec Pharma Inc. (NTEC) stock declines during current market after a massive upraise. What’s happening?

Intec Pharma Inc. (NASDAQ: NTEC) stock drops by 7.88% during the current market trading session. Intec Pharma is a clinical-stage biopharmaceutical firm specializing in...

Related News

Intec Pharma Inc. (NTEC) stock declines during current market after a massive upraise. What’s happening?

Intec Pharma Inc. (NASDAQ: NTEC) stock drops by 7.88% during the current market trading session. Intec Pharma is a clinical-stage biopharmaceutical firm specializing in...

F5 Networks Inc. (FFIV) stock soars during pre-market trading. Here’s to know why?

F5 Networks Inc. (FFIV) stock gained by 0.23% at the last close while the FFIV stock surged by 6.05% in the pre-market trading session....

Here is why Cerecor Inc. (CERC) stock turnaround in the after-hours on Monday?

Cerecor Inc. (CERC) shares gained 12.23% in after-hours on Monday, July 26, 2021, and closed the trading at $3.12. in the regular trading session,...

Here is why Bit Digital Inc. (BTBT) stock skyrocketed on Monday?

Bit Digital Inc. (BTBT) shares declined 10.94% in after-hours on Monday, July 26, 2021, and closed the day at $7.90. Earlier in the regular...

Why did Protagenic Therapeutics Inc. (PTIX) stock commence the new week with a negative trend?

Protagenic Therapeutics Inc. (PTIX) shares declined 13.82% in the pre-market on Monday, July 26, 2021, as of this writing. In after-hours on Friday, Protagenic...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

100% free. stop anytime no spam